RecruitingNCT07425574

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

Studying Stargardt disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Astellas Pharma Global Development, Inc.
Principal Investigator
Medical Director
Astellas Pharma Global Development, Inc.
Intervention
No Intervention(other)
Enrollment
90 target
Eligibility
6 years · All sexes
Timeline
20262028

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07425574 on ClinicalTrials.gov

Other trials for Stargardt disease

Additional recruiting or active studies for the same condition.

See all trials for Stargardt disease

← Back to all trials